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The use of multiple medications (polypharmacy) in older people (>65 years) is common clinical practice 
and increasingly recognised as potentially problematic rather than always inappropriate. Accordingly, 
assessments of prescribing appropriateness need to differentiate between ‘many’ medicines (appropriate 
polypharmacy) and ‘too many’ medicines (inappropriate polypharmacy).[1] Selecting the most effective 
interventions to ensure appropriate polypharmacy in older people remains challenging. 
 
 The aim of this Cochrane review was to determine the effectiveness of interventions seeking to improve 
appropriate use of polypharmacy in older people, by updating the review which was published in 
2014.[2] 
 
A systematic review was undertaken using standard Cochrane methodology. A range of electronic 
databases (e.g. EMBASE, MEDLINE) were searched for articles published between November 2013 
and May 2016 using relevant search terms (e.g. 'polypharmacy', 'inappropriate prescribing') as per 
original review.[2] Eligible studies (randomised controlled trials, non-randomised controlled clinical 
trials, controlled before-and-after studies, interrupted time-series studies) evaluated interventions aimed 
at improving appropriate polypharmacy in older people, using validated measures of prescribing 
appropriateness [e.g. Beers criteria, Medication Appropriateness Index (MAI)]. Primary outcomes of 
interest were changes in the prevalence of appropriate polypharmacy and hospital admissions. 
Secondary outcomes included medication-related problems (e.g. adverse drug reactions). Two review 
authors independently screened abstracts, extracted data and assessed risk of bias for included studies. 
Study-specific estimates were pooled for explicit/criterion-based measures (e.g. Beers) and 
implicit/judgement-based measures (e.g. MAI) of prescribing appropriateness using a random-effects 
model to yield summary effect estimates and 95% confidence intervals (CIs). The GRADE approach 
was used to assess the quality of evidence for pooled effect estimates. Ethical approval was not required. 
 
Eight studies were added to the review bringing the total number of included studies to 20, involving 
25,674 participants. Two interventions involved computerised decision-support and the remainder 
comprised complex pharmaceutical care-based interventions across various clinical settings. Changes 
in medication appropriateness scores using implicit tools showed a greater reduction in 
inappropriateness between baseline and follow-up in intervention groups compared to control groups 
(mean difference -6.34, 95% CI -12.23, -0.45). Assessments of the number of potentially inappropriate 
medications (PIMs) and potential prescribing omissions (PPOs) using explicit tools showed fewer PIMs 
(standardised mean difference -1.06, 95% CI -2.01, -0.12) and fewer PPOs per participant (standardised 
mean difference -0.81, 95% CI -0.98, -0.64) in intervention groups compared to control groups post-
intervention. The proportion of patients prescribed ≥1 PIM (relative risk 0.61, 95% CI 0.42-0.89) was 
lower in intervention groups compared to control groups post-intervention. The overall quality of 
evidence for all pooled outcomes was low or very low. Evidence of the effects of interventions on 
hospital admissions and medication-related problems was conflicting. 
 
This updated review found that included intervention studies reduced inappropriate prescribing for older 
people receiving polypharmacy. However, the quality of evidence from pooling data across studies 
remains weak. It is also still unclear whether interventions resulted in clinically significant 
improvements for patients. Future intervention studies could benefit from available guidance relating 
to intervention development, evaluation and reporting. 
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